Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians

Aesthetic Plastic Surgery

Volumn 30, Issue 6, 2006, Pages 689-694

  Sato, Katsujiro ^a   Matsumoto, Daisuke ^a   Iizuka, Fumiko ^a   Aiba Kojima, Emiko ^a   Watanabe Ono, Asami ^b   Suga, Hirotaka ^a   Inoue, Keita ^a   Gonda, Koichi ^a   Yoshimura, Kotaro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Ritz Medical Clinic   (Japan)

Author keywords

Acne vulgaris; Anti androgenic therapy; Contraceptive; Hormonal therapy; Oral spironolactone; Testosterone

Indexed keywords

ANTIANDROGEN; ESTRADIOL BENZOATE; HYDROXYPROGESTERONE CAPROATE; SPIRONOLACTONE;

ACNE VULGARIS; ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; ASIAN; CHLORIDE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EDEMA; ELECTROLYTE BLOOD LEVEL; FATIGUE; FEMALE; GYNECOMASTIA; HEADACHE; HORMONE BLOOD LEVEL; HUMAN; JAPAN; LEG EDEMA; LETHARGY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; PAPULE; PRIORITY JOURNAL; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; URINARY FREQUENCY;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ALDOSTERONE ANTAGONISTS; ASIAN CONTINENTAL ANCESTRY GROUP; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 33845485676     PISSN: 0364216X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00266-006-0081-0     Document Type: Article

References (20)

1. Allen BS, Smith JG Jr: Various parameters for grading acne vulgaris. Arch Dermatol 118:23-25, 1982
2. Carmina E, Stanczyk FZ, Matteri RK, Lobo RA: Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women. Fertil Steril 55:872-876, 1991
3. Cooper AJ: Treatment of acne with isotretinoin: Recommendations based on Australian experience. Australian Roaccutane Advisory Board. Australas J Dermatol 44:97-105, 2003
4. Goulden V, Clark SM, Cunliffe WJ: Postadolescent acne: A review of clinical features. Br J Dermatol 136:66-70, 1997
5. Kasper P: Cyproterone acetate: A genotoxic carcinogen? Pharmacol Toxicol 88:223-231, 2001
6. Lucky AW, McGuire J, Rosenfield RL, Lucky PA, Rich BH: Plasma androgens in women with acne vulgaris. J Invest Dermatol 81:70-74, 1983
7. Masahashi T, Wu MC, Ohsawa M, Asai M, Ichikawa Y, Hanai K, Kikkawa H, Mizutani S, Narita O, Tomoda Y: Spironolactone therapy for hyperandrogenic anovulatory women: Clinical and endocrinological study. Nippon Sanka Fujinka Gakkai Zasshi 38:95-101, 1986
8. Messina M, Manieri C, Musso MC, Pastorino R: Oral and topical spironolactone therapies in skin androgenization. Panminerva Med 32:49-55, 1990
9. Muhlemann MF, Carter GD, Cream JJ, Wise P: Oral spironolactone: An effective treatment for acne vulgaris in women. Br J Dermatol 115:227-232, 1986
10. Ng PP, Goh CL: Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients. Int J Dermatol 38:213-216, 1999
11. Parys BT, Hamid S, Thomson RG: Severe hepatocellular dysfunction following cyproterone acetate therapy. Br J Urol 67:312-313, 1991
12. Satoh T, Itoh S, Seki T, Itoh S, Nomura N, Yoshizawa I: On the inhibitory action of 29 drugs having side effect gynecomastia on estrogen production. J Steroid Biochem Mol Biol 82:209-216, 2002
13. Shaw JC: Low-dose adjunctive spironolactone in the treatment of acne in women: A retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol 43:498-502, 2000
14. Shaw JC, White LE: Long-term safety of spironolactone in acne: Results of an 8-year follow-up study. J Cutan Med Surg 6:541-545, 2002
15. Slayden SM, Moran C, Sams WM Jr, Boots LR, Azziz R: Hyperandrogenemia in patients presenting with acne. Fertil Steril 75:889-892, 2001
16. Takashima E, Iguchi K, Usui S, Yamamoto H, Hirano K: Metabolite profiles of flutamide-induced hepatic dysfunction. Biol Pharm Bull 26:1455-1460, 2003
17. Thiboutot D, Chen W: Update and future of hormonal therapy in acne. Dermatology 206:57-67, 2003
18. Vexiau P, Husson C, Chivot M, Brerault JL, Fiet J, Julien R, Villette JM, Hardy N, Cathelineau G: Androgen excess in women with acne alone compared with women with acne and/or hirsutism. J Invest Dermatol 94:279-283, 1990
19. Wysowski DK, Freiman JP, Tourtelot JB, Horton ML III: Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med 118:860-864, 1993
20. Zouboulis CC, Martin JP: Update and future systemic acne treatment. Dermatology 206:37-53, 2003